Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Pain 14Neoplasms 6Colonic Neoplasms 5Agnosia 5Lung Neoplasms 4Head and Neck Neoplasms 4Cancer Pain 4Breast Neoplasms 4Rectal Neoplasms 3Prostatic Neoplasms 3Pain, Postoperative 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Pancreatic Neoplasms 2Lymphoma, Follicular 2Diverticulosis, Colonic 2Chronic Pain 2Breakthrough Pain 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thrombocythemia, Essential 1Terminal Cancer 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1

Interventions

Low-Level Light Therapy 5Radiation 4Radiotherapy 3Propolis 3Morphine 3Methotrexate 3Leucovorin 3Cryotherapy 3Cisplatin 3glucarpidase 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2Fibroblast Growth Factor 7 2Drug Therapy 2Amifostine 2peppermint oil 1pegfilgrastim 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1maltodextrin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucositis × Fentanyl × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡